Lingxiang Wu

机构：Yunnan Agricultural University, Chinese Academy of Sciences, Institute of Automation · ORCID：0000-0003-4631-1229

发表论文 85 篇 · 总被引 1859 次 · h-index 19

代表论文

• Sex-based clinical and immunological differences in COVID-19 (2021 · BMC Infectious Diseases · 被引 217)
• Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling (2021 · Cell Research · 被引 179)
• Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma (2021 · Journal of Clinical Investigation · 被引 146)
• Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer (2023 · Nature Communications · 被引 66)
• HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression (2021 · Circulation · 被引 64)
• High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis (2021 · Frontiers in Oncology · 被引 30)